This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: University of Michigan. Active years: 2015-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2016
Title: Yali Dou: Innovator in Cancer Treatment
Introduction
Yali Dou is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of cancer research through his innovative work. With a total of 2 patents, Dou is recognized for his advancements in the inhibition of specific protein interactions that play a crucial role in cancer progression.
Latest Patents
Dou's latest patents include groundbreaking discoveries in the inhibition of WDR5 interaction with its binding partners. One of his patents discloses peptidomimetics that inhibit the interaction between MLL1 and WDR5. This innovation also outlines methods for inhibiting MLL1 activity and treating cancers. Another patent focuses on cyclized peptidomimetic small molecule inhibitors of the WDR5 and MLL1 interaction, further detailing methods for inhibiting MLL1 activity and cancer treatment.
Career Highlights
Yali Dou is affiliated with the University of Michigan, where he continues to push the boundaries of cancer research. His work has garnered attention for its potential impact on therapeutic strategies for cancer treatment.
Collaborations
Dou collaborates with esteemed colleagues, including Shaomeng Wang and Hacer Karatas, who contribute to his research endeavors.
Conclusion
Yali Dou's innovative work in cancer treatment through his patented inventions highlights his commitment to advancing medical science. His contributions are paving the way for new therapeutic approaches in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile